SMS Pharmaceuticals Ltd Sustainability Profile
SMS Pharmaceuticals Ltd, a prominent player in the pharmaceutical industry, is headquartered in India and operates extensively across various regions. Founded in 1987, the company has established itself as a leader in the production of active pharmaceutical ingredients (APIs) and formulations, catering to both domestic and international markets. With a diverse portfolio that includes anti-infectives, anti-diabetics, and cardiovascular medications, SMS Pharmaceuticals is recognised for its commitment to quality and innovation. The company’s state-of-the-art manufacturing facilities adhere to stringent regulatory standards, ensuring the delivery of high-quality products. Notable achievements include successful collaborations with global pharmaceutical firms and a strong market presence in Europe and the Americas. SMS Pharmaceuticals Ltd continues to drive advancements in healthcare, making significant contributions to the pharmaceutical landscape.
DitchCarbon Score
How does SMS Pharmaceuticals Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
SMS Pharmaceuticals Ltd's score of 32 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
SMS Pharmaceuticals Ltd's reported carbon emissions
In 2024, SMS Pharmaceuticals Ltd reported total carbon emissions of approximately 37,382,480 kg CO2e for Scope 1, 42,378,970 kg CO2e for Scope 2, and 200,610 kg CO2e for Scope 3. This reflects a significant increase in emissions compared to 2023, where the company recorded about 32,757,700 kg CO2e in Scope 1, 28,551,170 kg CO2e in Scope 2, and 31,870 kg CO2e in Scope 3. In 2022, emissions were approximately 25,759,670 kg CO2e for Scope 1, 31,505,800 kg CO2e for Scope 2, and 32,500 kg CO2e for Scope 3. Despite these figures, SMS Pharmaceuticals Ltd has not set specific reduction targets or climate pledges, indicating a potential area for improvement in their sustainability strategy. The company operates independently without cascading emissions data from a parent organisation, ensuring that their reported figures are solely reflective of their own operations. Overall, while SMS Pharmaceuticals Ltd has made strides in transparency regarding their emissions, the absence of defined reduction initiatives suggests a need for enhanced commitment to climate action in the pharmaceutical industry.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 25,759,670 | 00,000,000 | 00,000,000 |
| Scope 2 | 31,505,800 | 00,000,000 | 00,000,000 |
| Scope 3 | 32,500 | 00,000 | 000,000 |
How Carbon Intensive is SMS Pharmaceuticals Ltd's Industry?
How Carbon Intensive is SMS Pharmaceuticals Ltd's Location?
SMS Pharmaceuticals Ltd's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
SMS Pharmaceuticals Ltd has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
